| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.007 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |